Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Current Cancer Drug Targets|August 27, 2022
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem CellsSreedhar Reddy Suthe, Hang-Ping Yao, Tian-Hao Weng, et al.
Therapeutic Advances in Medical Oncology|May 20, 2020
Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers: antibody-drug conjugates as lead drug candidates for clinical trialsHang-Ping Yao, Sreedhar Reddy Suthe, Xiang-Min Tong, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|January 23, 2003
[Effects of intrasplenic transplantation of IL-18 gene-modified fetal hepatocytes on mouse immune function]Hang-Ping Yao, Li-Huang Zhang, Wen-Ji Sun, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|February 5, 2005
[Construction of the eukaryotic expression vector containing rat transforming growth factor beta type II receptor and interferon gamma fusion genes]Zi-yang Yu, Li-huang Zhang, Hang-ping Yao, et al.
Experimental Dermatology|January 25, 2011
Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary reportWei-Qiang Tan, Zheng-Jun Gao, Jing-Hong Xu, et al.
RSC Advances|May 9, 2022
Enhanced hydrogen evolution from water splitting based on ZnO nanosheet/CdS nanoparticle heterostructuresYinwei Wang, Hang Ping, Tiening Tan, et al.
National Science Review|November 14, 2025
Idea of biomineralization-inspired fabrication for ceramics at room or low temperatureZhaoyong Zou, Hang Ping, Qunfeng Cheng, et al.
Current Cancer Drug Targets|December 24, 2021
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine KinaseRachel Hudson, Hang-Ping Yao, Sreedhar Reddy Suthe, et al.
Zhonghua Yi Xue Za Zhi|May 22, 2003
[Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice]Yue-long Pan, Shu Zheng, Zuo-xiang Xiao, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|August 24, 2010
[Expression of B7-H4 in prostate cancer and its clinical significance]Yun Qian, Hang-ping Yao, Ling Shen, et al.
Pageof 19